<?xml version="1.0" encoding="UTF-8"?>
<p id="par0020">A multisystem inflammatory syndrome, similar to Kawasaki disease, has recently been recognized, and may be associated with SARS-CoV-2 infection, perhaps as a post-infectious inflammatory syndrome. One quarter of these cases may develop coronary vascular damage and other cardiac complications. As there is growing evidence of a link between a SARS CoV-2 infection and this inflammatory syndrome (
 <xref rid="bib0065" ref-type="bibr">Verdoni et al., 2020</xref>), the condition should be included as a potential adverse event of special interest in vaccine studies. Although it is thought that some of the described cases do not have any evidence of an immune response to SARS-CoV-2, it is still unclear whether the phenomenon could be mediated by immune responses to novel vaccines.
</p>
